Sarepta Therapeutics, Inc. Earnings

Sarepta Therapeutics, Inc.’s revenue jumped 40.79% since last year same period to $467.17Mn in the Q3 2024. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 28.72% jump in its revenue since last 3-months.

Sarepta Therapeutics, Inc.’s net profit jumped 182.1% since last year same period to $33.61Mn in the Q3 2024. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 420.29% jump in its net profits since last 3-months.

Sarepta Therapeutics, Inc.’s net profit margin jumped 158.32% since last year same period to 7.19% in the Q3 2024. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 304.2% jump in its net profit margins since last 3-months.

Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.13 - a -1400% fall from last quarter’s estimates.

Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.13.

Sarepta Therapeutics, Inc.’s earning per share (EPS) jumped 173.91% since last year same period to 0.34 in the Q3 2024. This indicates that the Sarepta Therapeutics, Inc. has generated 173.91% annual rate of jump in its earning per share (EPS) in the last 4 quarters.